Pirinixic acid is a peroxisome proliferator-activated receptor alpha (PPARα) agonist that is under experimental investigation for prevention of severe cardiac dysfunction cardiomyopathy and heart failure as a result of lipid accumulation within cardiac myocytes.
This page contains content from the copyrighted Wikipedia article "Pirinixic acid"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
